Navigation Links
ETEX Corporation Announces Additional FDA Clearance For EquivaBone(R), The First Hard Setting Osteoconductive and Osteoinductive Bone Graft Substitute.
Date:10/1/2009

CAMBRIDGE, Mass., Oct. 1 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, announced today additional FDA 510(k) cleared indications for EquivaBone®. EquivaBone was the first FDA cleared hard-setting osteoinductive material and is the only osteoinductive bone graft substitute that provides a continuous nanocrystalline calcium phosphate scaffold.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080424/NETH117LOGO )

EquivaBone is now additionally indicated for use in posterolateral spine fusion, providing spine surgeons a product that combines the certified osteoinductivity of DBM with the optimal handling and hard setting characteristics of the clinically proven ETEX calcium phosphate osteoconductive scaffold.

In addition, the clearance allows EquivaBone to be mixed with autologous blood, adding greater procedural flexibility. The resultant viscous putty can then be molded and packed or injected into a defect.

Brian Ennis, President and CEO of ETEX Corporation, comments, "ETEX is pleased with the rapid expansion of clinical indications for our innovative biologic portfolio. Our product improvements and line extensions remain driven by direct surgeon feedback. This is reflected in the recent clearance of small size EquivaBone kits and the addition of blood and posterolateral spinal fusion indications to the labeling. We anticipate additional indications and platform extensions in the near term."

EquivaBone is a proprietary combination of osteoinductive Demineralized Bone Matrix (DBM) and ETEX's osteoconductive nanocrystalline calcium phosphate. ETEX is proud to offer the first combination product that is both moldable and injectable and sets hard once implanted. In addition, the osteoinductivity of the DBM is certified after sterilization, by lot, for the entirety of shelf life.

About ETEX C
'/>"/>

SOURCE ETEX Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. CEL-SCI Corporation Releases Letter to Shareholders
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
5. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
6. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
7. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
10. Immunosyn Corporation Releases SF-1019 Study Results
11. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)...  Quest Diagnostics (NYSE: DGX ), the ... that its Board of Directors has elected Jeffrey M. ... 1, 2014. Including Dr. Leiden, the Board has 11 ... and CEO of Vertex Pharmaceuticals.   Dr. Leiden has ... in the pharmaceutical and biotechnology industries as well as ...
(Date:10/22/2014)... Antigen Discovery Inc. (ADi), a privately held ... the receipt of a National Institutes of Health (NIH) ... Institute of Dental and Craniofacial Research (NIDCR). The one-year ... Protein Microarray Chip, which will contain every protein in ... in the development of safe and effective vaccines and ...
(Date:10/22/2014)... Oct. 22, 2014   Reproductive Medicine Associates ... in the field of infertility, presents new clinical ... screening. The research abstract, released during the 70 ... (ASRM) meeting in Honolulu, Hawaii ... gene defect (SGD) pre-implantation genetic diagnosis (PGD). ...
Breaking Medicine Technology:Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3
... NEW ORLEANS, Feb. 17, 2012  New research looks at whether clot-busting ... research was released today and will be presented at the ... April 21 to April 28, 2012. In adults, the ... after stroke symptoms begin. But few studies have looked at whether ...
... Pharmos Corporation (OTC-PINK: PARS) today reported financial results for ... These results are included in the Company,s Yearly Report on ... Fourth Quarter Ended December 31, 2011The Company recorded ... for the fourth quarter 2011 compared to a net loss ...
Cached Medicine Technology:Is Clot-Busting Drug Safe for Kids with Strokes? 2Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results 2Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results 3Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results 4Pharmos Corporation Reports 2011 Fourth Quarter and Full Year Results 5
(Date:10/22/2014)... 22, 2014 Healthcare professionals who ... continuing education at home or on-the-go via laptops, ... 20 brand new, premium Seminar-on-Demand CE courses. The ... over 2,000 hours of CE course ... educational experience. With such a diverse library, there’s ...
(Date:10/22/2014)... Akeso Biomedical, Inc. , a ... of bacterial infections, microbial biofilms, and chronic wounds, announced ... of directors. , Dr. Sinskey is ... Massachusetts Institute of Technology, or MIT. He has been ... Sinskey also holds positions as Co-Director of the Malaysia-MIT ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, ... vitro fertilization (IVF) -- the incubation of embryos in a ... inside the vagina, new research suggests. Scientists from the ... INVOcell, might sharply cut costs for pricey IVF procedures among ... to those who don,t live near big-city assisted reproduction centers, ...
(Date:10/20/2014)... Orlando, Florida (PRWEB) October 20, 2014 ... fired-up former Gov. Charlie Crist made a brief fundraising ...  in Orlando on Thursday. , Fresh from a debate ... refused to take the stage for the first seven ... podium, the former governor described the incident in one ...
(Date:10/20/2014)... T.E.N., a technology and information ... that William H. Murray, renowned author and industry ... Leadership Award winner. Presented annually, the ISE® Luminary ... leader and industry practitioner for his or her ... information security industry. , Formerly with IBM, Murray ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4
... (HealthDay News) -- Abnormalities identified on the right side of ... and lungs, according to new research. In conducting ... or lower right chamber, researchers found that the size and ... differs, depending on their age, gender and race or ethnicity. ...
... plans to divert more mentally ill people out of the ... to be achieved, according to new research from Queen Mary, ... International Journal of Law and Psychiatry , researchers estimate that ... in prisons in England and Wales. If transferred to hospital, ...
... increasingly more common disease striking overweight, younger women is ... University, where an osteopathic physician is testing the effectiveness ... Idiopathic intracranial hypertension, known as IIH or pseudo-tumor ... around the brain, specifically in the absence of a ...
... WASHINGTON, DC, June 7, 2011 A new study ... while family members often provide critical support, they also ... impede the recovery of mentally ill relatives. "Negative ... the ways that mentally ill persons view themselves, adversely ...
... 6, 2011 An analysis linking federal bankruptcy court ... cancer cases in western Washington during a 14-year period ... increase along with the length of survival. "Patients ... to income loss and out-of-pocket costs associated with their ...
... undergo elective total hip or total knee arthroplasty at ... of venous thromboembolism and mortality following the procedure. The ... be reduced by modifying systems and procedures used before ... in Arthritis & Rheumatism , a peer-reviewed journal ...
Cached Medicine News:Health News:Right Side of Heart Linked to Lung Diseases, Study Finds 2Health News:Researcher tests drug's impact on neurological disease affecting women 2Health News:Study: What mom thinks matters when it comes to mental illness 2Health News:Study finds bankruptcy rates among cancer patients increase along with survival time 2Health News:Joint replacement surgery riskier at hospitals with low surgical volume 2
The 8500 is an extremely reliable portable pulse oximeter, requiring no periodic maintenance or calibration....
The miniSPO 2 T has the same advanced DOX digital technology as our multiple parameter vital signs monitors and lets you evaluate oxygen saturation and heart rate in a broad range of patients, from n...
Rad-5 signal extraction pulse oximeter™...
... Digital Handheld Pulse Oximeter provides ... patients monitoring - from spot ... the first pocket-size, handheld oximeter, ... for durability and enduring performance ...
Medicine Products: